With the state of Oregon's move to decriminalize drugs, the stigma around compounds like ketamine is lessening.
The shares have more than doubled from their March nadir.
The short answer? Yes!
Here's what might happen next for shares of the pet insurance company.
It's so huge. Hard to grasp. It's incredible.
The firm's Q3 earnings easily beat Wall Street's expectations.
Let's see if UNH and CI are what the doctor ordered.
Is Teladoc's merger with Livongo Health a 'game changer' for the stock?
The company is set to report earnings Tuesday.
With 33 years of consecutive dividend increases, this health care name is a member of the Dividend Aristocrats Index.